This is a procedural disclosure update with no financial implications. Traders should note that the company continues to operate with substantial doubt about its going concern status, but this amendment does not alter the fundamental financial picture.
Price Chart
Executive Summary
Quantum Genesis AI Corp. filed an amended 10-Q/A solely to update disclosures in Management's Discussion and Analysis regarding the formal assignment of intellectual property rights from its CEO, previously acquired under an Asset Purchase Agreement. No financial restatements were made, and the amendment is routine in nature.
Key Facts
- The 10-Q/A amends only Item 2 (MD&A) to include additional disclosure about intellectual property formalization.
- No changes were made to financial statements, notes, or other financial disclosures.
- The company entered into an Assignment Agreement with its CEO to confirm transfer of IP rights related to enzyme design technologies and a patent application for Modified Polypeptides for Enzymatic Synthesis of Ibuprofen.
- The assignment was effective as of November 2, 2023, but was formally documented during the reporting period.
- This filing follows a prior NT 10-K late filing notification, indicating prior reporting delays.
Financial Impact
No financial impact — no restatement or changes to income statement, balance sheet, or cash flow statement.
Risk Factors
- Continuing going concern uncertainty due to accumulated deficits and recurring losses.
- Past late filing history raises potential concerns about internal controls or reporting reliability.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 10-Q/A Filing (Primary) | 0001477932-26-002258 |
| Document: qtzm_ex311.htm | 0001477932-26-002258 |
| Document: qtzm_ex321.htm | 0001477932-26-002258 |
| Document: 0001477932-26-002258-index-headers.html | 0001477932-26-002258 |
| Document: 0001477932-26-002258-index.html | 0001477932-26-002258 |
| Document: 0001477932-26-002258.txt | 0001477932-26-002258 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Apr 15, 2026 27w ago | 10-Q/A | $0.2100 $0.0850 | ▼ −59.52% | ▼ −65.57% | $0.0459 (−78.14%) |
Apr 15, 2026 27w ago | 10-Q/A | $0.2100 $0.0850 | ▼ −59.52% | ▼ −65.57% | $0.0459 (−78.14%) |
Apr 15, 2026 27w ago | 10-K/A | $0.2100 $0.0850 | ▼ −59.52% | ▼ −65.57% | $0.0459 (−78.14%) |
Apr 15, 2026 27w ago | 8-K | $0.2100 $0.0850 | ▼ −59.52% | ▼ −65.57% | $0.0459 (−78.14%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers